These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37600024)

  • 1. Editorial: Innovative strategies for the management of life threatening ventricular tachyarrhythmias-from substrate analysis to differential therapy.
    Höltgen R; Bogossian H; Bandorski D
    Front Cardiovasc Med; 2023; 10():1264493. PubMed ID: 37600024
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia.
    Corrado D; Basso C; Leoni L; Tokajuk B; Turrini P; Bauce B; Migliore F; Pavei A; Tarantini G; Napodano M; Ramondo A; Buja G; Iliceto S; Thiene G
    J Am Coll Cardiol; 2008 Feb; 51(7):731-9. PubMed ID: 18279737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias.
    Otuki S; Hasegawa K; Watanabe H; Katsuumi G; Yagihara N; Iijima K; Sato A; Izumi D; Furushima H; Chinushi M; Aizawa Y; Minamino T
    J Electrocardiol; 2017; 50(3):277-281. PubMed ID: 28238302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical storm in systemic sclerosis: Inside the electroanatomic substrate.
    Casella M; Carbucicchio C; Russo E; Pizzamiglio F; Golia P; Conti S; Costa F; Dello Russo A; Tondo C
    World J Cardiol; 2014 Oct; 6(10):1127-30. PubMed ID: 25349658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate dynamics and vulnerability to ventricular tachyarrhythmias.
    Huikuri HV
    Ann Med; 1997 Aug; 29(4):321-5. PubMed ID: 9375990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Thiene G; Corrado D; Basso C
    Orphanet J Rare Dis; 2007 Nov; 2():45. PubMed ID: 18001465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeled left ventricular myocardium remote to infarction sites is the arrhythmogenic substrate for sudden cardiac death.
    Tsai CF; Ueng KC; Wu DJ; Tsai TP; Lin CS
    Med Hypotheses; 2010 Oct; 75(4):368-71. PubMed ID: 20399566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification personalised model for prediction of life-threatening ventricular tachyarrhythmias in patients with chronic heart failure.
    Frolov AV; Vaikhanskaya TG; Melnikova OP; Vorobiev AP; Guel LM
    Kardiol Pol; 2017; 75(7):682-688. PubMed ID: 28708197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases?
    Furushima H; Chinushi M; Iijima K; Hasegawa K; Sato A; Izumi D; Watanabe H; Aizawa Y
    Europace; 2012 May; 14(5):675-81. PubMed ID: 22158850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of ventricular fibrillation triggers and electrical storm.
    Tan VH; Yap J; Hsu LF; Liew R
    Europace; 2012 Dec; 14(12):1687-95. PubMed ID: 22431442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological mechanisms of ventricular tachyarrhythmias.
    Breithardt G; Borggrefe M; Martinez-Rubio A; Budde T
    Eur Heart J; 1989 Sep; 10 Suppl E():9-18. PubMed ID: 2680507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death.
    Pappone C; Ciconte G; Anastasia L; Gaita F; Grant E; Micaglio E; Locati ET; Calovic Z; Vicedomini G; Santinelli V
    Europace; 2023 Mar; 25(3):948-955. PubMed ID: 36610790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical storm reveals worse prognosis compared to myocardial infarction complicated by ventricular tachyarrhythmias in ICD recipients.
    Müller J; Behnes M; Schupp T; Ellguth D; Taton G; Reiser L; Engelke N; Borggrefe M; Reichelt T; Bollow A; El-Battrawy I; Weidner K; Kim SH; Barth C; Ansari U; Große Meininghaus D; Akin M; Mashayekhi K; Akin I
    Heart Vessels; 2021 Nov; 36(11):1701-1711. PubMed ID: 33900449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation and management of electrical storm.
    Eifling M; Razavi M; Massumi A
    Tex Heart Inst J; 2011; 38(2):111-21. PubMed ID: 21494516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of ventricular tachyarrhythmias and prevention of sudden cardiac death: commentary on the 2016 ESC guideline].
    Eckardt L; Köbe J; Wasmer K
    Dtsch Med Wochenschr; 2016 Aug; 141(16):1154-7. PubMed ID: 27509343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management.
    Sattar Y; Abdullah HM; Neisani Samani E; Myla M; Ullah W
    Cureus; 2019 Aug; 11(8):e5381. PubMed ID: 31616612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
    J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
    Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
    Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.